Healthcare >> CEO Interviews >> October 17, 2011
William H. Critchfield, CPA, is Senior Vice President of Operations and Finance and Chief Financial Officer of Corgenix Medical Corporation. Before joining Corgenix, he was Executive Vice President and Chief Financial Officer of U.S. Medical, Inc., a Denver-based privately held distributor of new and used capital medical equipment. From 1994 to 1999 he served as President and Chief Financial Officer of WLC Enterprises Inc., a retail business holding company. From 1991 to 1994, he served as Executive Vice President and Chief Financial Officer of Air Methods Corporation, a publicly traded company in the air medical transportation industry and the successor company to Cell Technology, Inc. Mr. Critchfield served in a similar capacity for Cell Technology, a publicly traded biotechnology company. From 1986 to 1987 he served as Vice President of Finance and Administration for Biostar Medical Products, Inc., a developer and manufacturer of diagnostic immunoassays. He also has served as Vice President of Finance for Nuclear Pharmacy, Inc., a publicly traded company and chain of centralized radiopharmacies. He graduated magna cum laude from California State University at Northridge with a B.S. in business administration. Profile
TWST: Would you begin with a brief historical sketch of Corgenix and a picture of the company's operations at the present time?
Mr. Critchfield: Basically, Corgenix (CONX)is a medical diagnostic firm
